Therapeutic Apheresis and Dialysis最新文献_第10页

Clinical study on the correlation between monocyte-related ratios and calcification of the abdominal aorta in peritoneal dialysis patients. 腹膜透析患者单细胞相关比值与腹主动脉钙化相关性的临床研究。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13978

Jiani Sun, Yuan Lu, Lei Shen, Deyu Xu, Wengang Sha, Ling Zhou, Jianzhong Li

{"title":"Clinical study on the correlation between monocyte-related ratios and calcification of the abdominal aorta in peritoneal dialysis patients.","authors":"Jiani Sun, Yuan Lu, Lei Shen, Deyu Xu, Wengang Sha, Ling Zhou, Jianzhong Li","doi":"10.1111/1744-9987.13978","DOIUrl":"https://doi.org/10.1111/1744-9987.13978","url":null,"abstract":"Introduction: We aimed to investigate the relationship between monocyte/lymphocyte ratio (MLR) and monocyte/high-density lipoprotein ratio (MHR) with abdominal aortic calcification (AAC) in patients on peritoneal dialysis (PD).Methods: The time-averaged (TA) of relevant indexes and AAC scores (AACs) of 160 eligible patients were measured.Results: Patients divided into the new AAC (n = 57) and the other without (n = 82). High TA-MLR (OR = 110.537, p = 0.018) and long duration of dialysis (OR = 1.045, p < 0.001) were independent risk factors of the new AAC. Patients divided into the no AAC (n = 82), the moderate-to-severe AAC (n = 26), and the mild AAC (n = 52). High TA-MLR (OR = 42.649, p = 0.032), high age at starting PD (OR = 1.055, p < 0.001), and long duration of PD (OR = 1.036, p < 0.001) were independent risk factors of AAC severity.Conclusions: MLR is an independent risk factor for the occurrence and severity of AAC and its value for the assessment of AAC is better than MHR.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"742-751"},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9732769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Effect of dialyzer geometry on coagulation activation in the extracorporeal circuit in maintenance hemodialysis patients: Prospective randomized trial. 透析器几何形状对维持性血液透析患者体外循环凝血激活的影响:前瞻性随机试验。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13975

Hesham ElSayed, Khalid Samir Sayed, Mohamed Sary Gharib

{"title":"Effect of dialyzer geometry on coagulation activation in the extracorporeal circuit in maintenance hemodialysis patients: Prospective randomized trial.","authors":"Hesham ElSayed, Khalid Samir Sayed, Mohamed Sary Gharib","doi":"10.1111/1744-9987.13975","DOIUrl":"https://doi.org/10.1111/1744-9987.13975","url":null,"abstract":"Background and objectives: The coagulation cascade is activated during hemodialysis (HD) due to interaction of blood with the dialysis circuit. There is a paucity of data on the effect of the physical structure of the dialyzers on coagulation activation during HD. We conducted this study to compare the effect of Helixone FX80 versus Platinum H4 dialyzers on coagulation activation during HD.Methods: Twenty patients on maintenance HD were enrolled in this randomized prospective crossover study. Each patient was dialyzed using Helixone FX80 and Platinum H4 dialyzers. Serum thrombin-antithrombin complex (TAT) was measured before (T0h) and at the end (T4H) of HD.Results: The absolute changes of serum TAT were comparable with the two dialyzers (median [IQR]: 1.15 [0.65, 1.75] for Helixone FX80 vs. 1.15 [0.67, 2.05] for Platinum H4, p = 0.371).Conclusion: Helixone FX80 and Platinum H4 dialyzers have similar effects on coagulation activation during HD.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"629-635"},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9739313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Corporate Members. 公司成员。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13877

引用次数: 0

The impact of COVID-19 pandemic on anxiety levels among patients who have to go to the hospital due to chronic illnesses: A prospective study. COVID-19大流行对因慢性疾病而不得不去医院的患者焦虑水平的影响:一项前瞻性研究

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13971

Pervin Ozkan Kurtgoz, Fatih Sackan, Irem Oner, Ozlem Bilgin, Deniz Ozdemir, Suleyman Karakose, Mehmet Ali Eryılmaz, Ibrahim Guney, Muhammet Cemal Kızılarslanoglu

{"title":"The impact of COVID-19 pandemic on anxiety levels among patients who have to go to the hospital due to chronic illnesses: A prospective study.","authors":"Pervin Ozkan Kurtgoz, Fatih Sackan, Irem Oner, Ozlem Bilgin, Deniz Ozdemir, Suleyman Karakose, Mehmet Ali Eryılmaz, Ibrahim Guney, Muhammet Cemal Kızılarslanoglu","doi":"10.1111/1744-9987.13971","DOIUrl":"https://doi.org/10.1111/1744-9987.13971","url":null,"abstract":"Introduction: Cancer and hemodialysis (HD) patients are at high risk for COVID-19. In our study, we aimed to evaluate the effect of pandemic on anxiety in these patients.Methods: One hundred and six oncology and 97 HD patients participated in the study. Anxiety levels were assessed by using the Beck Anxiety Inventory (BAI) and State-Trait Anxiety Inventory (STAI). At the end of 8-month follow-up, these questionnaires were re-administered.Results: During this period, 38 patients (38/203; 18.7%) had COVID-19 infection. Twenty-three patients (23/203; 11.3%) died due to COVID-19 and/or other causes. One hundred and thirteen of the remaining patients were participated in the second questionnaire. Having COVID-19 was not the independent factor for changes in STAI, and BAI scores in any regression models.Conclusion: Having COVID-19 does not affect the increased anxiety levels in HD and oncology patients. The effect of the pandemic may have remained in the background, as these patients have more concerns about their own diseases.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"711-719"},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The effect of nonpharmacologic interventions for muscle cramps and restless-leg syndrome in hemodialysis patients: A meta-analysis of randomized controlled trials. 非药物干预对血液透析患者肌肉痉挛和不宁腿综合征的影响:随机对照试验的荟萃分析。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13968

Gulsah Kesik, Nese Altinok Ersoy

{"title":"The effect of nonpharmacologic interventions for muscle cramps and restless-leg syndrome in hemodialysis patients: A meta-analysis of randomized controlled trials.","authors":"Gulsah Kesik, Nese Altinok Ersoy","doi":"10.1111/1744-9987.13968","DOIUrl":"https://doi.org/10.1111/1744-9987.13968","url":null,"abstract":"Introduction: We performed a meta-analysis to evaluate the effect of the nonpharmacologic interventions on muscle related symptoms including cramping and restless leg syndrome in hemodialysis patients.Methods: Articles published between 2002 and 2022 were searched in six databases. The standardized mean differences were determined by the upper and lower limits of 95% confidence intervals. Publication bias was assessed by conducting the Egger test and examined visually using a funnel plot.Results: Fourteen studies were included in this meta-analysis. The types of interventions included exercise (n = 5), aromatherapy (n = 5), reflexology (n = 3), massage (n = 1), and acupressure (n = 1). The methodological quality assessment revealed 13 studies were strong quality, while only one study was moderate quality. The Egger test indicated no significant publication biases.Conclusion: Healthcare professionals can use non-pharmacological methods to manage muscle-related symptoms because of not only beneficial effects but also it is practical, well-tolerated, easy integrated into the treatment and care.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"636-654"},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Changes in erythropoiesis-stimulating agent responsiveness after transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis: A prospective multicenter study in Japan. 日本的一项前瞻性多中心研究:腹膜透析患者转入腹膜透析和血液透析联合治疗后促红细胞生成剂反应性的变化

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-08-01 DOI: 10.1111/1744-9987.13981

Yukio Maruyama, Keitaro Yokoyama, Chieko Higuchi, Tsutomu Sanaka, Yoshihide Tanaka, Ken Sakai, Yoshihiko Kanno, Munekazu Ryuzaki, Tsutomu Sakurada, Tatsuo Hosoya, Masaaki Nakayama

{"title":"Changes in erythropoiesis-stimulating agent responsiveness after transfer to combined therapy with peritoneal dialysis and hemodialysis for patients on peritoneal dialysis: A prospective multicenter study in Japan.","authors":"Yukio Maruyama, Keitaro Yokoyama, Chieko Higuchi, Tsutomu Sanaka, Yoshihide Tanaka, Ken Sakai, Yoshihiko Kanno, Munekazu Ryuzaki, Tsutomu Sakurada, Tatsuo Hosoya, Masaaki Nakayama","doi":"10.1111/1744-9987.13981","DOIUrl":"https://doi.org/10.1111/1744-9987.13981","url":null,"abstract":"Introduction: Inadequate dialysis and fluid overload are corrected after starting combined therapy with peritoneal dialysis (PD) and hemodialysis (HD). However, the effects on anemia management has not been elucidated.Methods: We conducted a prospective, multicenter, observational cohort study of 40 PD patients (age, 60 ± 10 years; male, 88%; median PD duration, 28 months) starting combined therapy and investigated changes in several clinical parameters, including erythropoiesis-stimulating agent (ESA) resistance index (ERI).Results: ERI decreased significantly during 6 months after switching to combined therapy (from 11.8 [IQR 8.0-20.4] units/week/kg/(g/dL) to 7.8 [IQR 3.9-18.6] units/week/kg/(g/dL), p = 0.047). Body weight, urinary volume, serum creatinine and the dialysate-to-plasma creatinine ratio (D/P Cr) decreased, whereas hemoglobin and serum albumin increased. In subgroup analysis, the changes in ERI were not affected by cause for starting combined therapy, PD holiday and D/P Cr.Conclusion: Although detailed mechanism was unclear, ESA responsiveness improved after switching from PD alone to combined therapy.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"735-741"},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9744970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Therapeutic Apheresis and Dialysis Forthcoming Events August 2023 治疗性采血和透析即将举行的活动2023年8月

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-07-02 DOI: 10.1111/1744-9987.13876

August

引用次数: 0

Issue Information 问题信息

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-07-02 DOI: 10.1111/1744-9987.13875

引用次数: 0

A case report of successful using interventional radiology with covered stents for a vascular access-related aneurysm. 有盖支架介入治疗血管通路相关动脉瘤成功的病例报告。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-06-01 DOI: 10.1111/1744-9987.13963

Yuta Goto, Takaya Abe, Wataru Obara

{"title":"A case report of successful using interventional radiology with covered stents for a vascular access-related aneurysm.","authors":"Yuta Goto, Takaya Abe, Wataru Obara","doi":"10.1111/1744-9987.13963","DOIUrl":"https://doi.org/10.1111/1744-9987.13963","url":null,"abstract":"The etiology of vascular access-related aneurysm (VARA) usually results from repeated cannulation in the same area of the access or caused by inadequate hemostasis after removal of needles during hemodialysis. Surgical management is indicated for the management of compli-cations such as rapid enlargement, overlying skin necrosis, or rupture. Rupture of a VARA is a lethal and requires emergency treatment. The definitive treatment for VARA is surgery, such as vascular repair. However, in cases with arterial bleeding, emergency vascular surgery is difficult to perform. As an alternative, interventional radiology (IVR) has been increasingly used as a minimally invasive and rapid procedure for bleeding arterial lesions. The advan-tages of IVR with covered stents compared with surgery for VARA include a shorter procedure time, lower risk of postoperative peripheral tissue ischemia, and preservation of vascular access (VA), whereas disadvantages include the risk of infection and occlusion and the contraindica-tion of a puncture at the covered stent site. This report pre-sents the case of a patient with a VARA rupture who underwent IVR with a covered stent to preserve VA func-tion and achieved hemostatic efficacy. A 64-year-old female","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 3","pages":"599-600"},"PeriodicalIF":1.9,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study. 维生素D受体激活剂对血液透析患者心血管事件的影响——LANDMARK研究的事后分析

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-06-01 DOI: 10.1111/1744-9987.13954

Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Akiko Takeshima, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida

{"title":"Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study.","authors":"Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Akiko Takeshima, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida","doi":"10.1111/1744-9987.13954","DOIUrl":"https://doi.org/10.1111/1744-9987.13954","url":null,"abstract":"Introduction: The clinical benefit of vitamin D receptor activators (VDRA) in patients with well-controlled secondary hyperparathyroidism undergoing dialysis remains unclear.Methods: This post hoc analysis of the LANDMARK study investigates if VDRA use is associated with cardiovascular benefits. Data of 2135 patients undergoing hemodialysis who were at risk for vascular calcification were analyzed using a Cox proportional hazards model with propensity-score matching.Results: The hazard ratio (HR) for VDRA use was 0.99 (95% confidence interval [CI]: 0.67-1.46; p = 0.945) for cardiovascular events and 0.89 (95% CI: 0.62-1.28; p = 0.541) for all-cause mortality at baseline. Among patients who always used VDRA, the HR was 1.12 (95% CI: 0.67-1.89; p = 0.666) for cardiovascular events and 1.11 (95% CI: 0.67-1.85; p = 0.688) for all-cause mortality compared to those who never used VDRA.Conclusion: The use of VDRA does not reduce the risks of cardiovascular events or all-cause mortality in patients on dialysis with well-controlled secondary hyperparathyroidism.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 3","pages":"523-529"},"PeriodicalIF":1.9,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9723713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0